Advertisement
Australia markets close in 7 minutes

  • ALL ORDS

    8,060.40
    -18.80 (-0.23%)
     

  • ASX 200

    7,813.10
    -18.70 (-0.24%)
     

  • AUD/USD

    0.6736
    +0.0008 (+0.12%)
     

  • OIL

    83.69
    -0.19 (-0.23%)
     

  • GOLD

    2,372.30
    +2.90 (+0.12%)
     

  • Bitcoin AUD

    81,056.34
    -6,306.54 (-7.22%)
     

  • CMC Crypto 200

    1,134.75
    -73.95 (-6.12%)
     

  • AUD/EUR

    0.6222
    +0.0002 (+0.04%)
     

  • AUD/NZD

    1.1003
    +0.0011 (+0.10%)
     

  • NZX 50

    11,794.81
    +48.15 (+0.41%)
     

  • NASDAQ

    20,186.63
    +174.74 (+0.87%)
     

  • FTSE

    8,241.26
    +70.14 (+0.86%)
     

  • Dow Jones

    39,308.00
    -23.90 (-0.06%)
     

  • DAX

    18,450.48
    +75.95 (+0.41%)
     

  • Hang Seng

    17,878.83
    -149.45 (-0.83%)
     

  • NIKKEI 225

    40,826.47
    -87.18 (-0.21%)
     

Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024

PR Newswire
·1-min read

ALAMEDA, Calif., July 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2024 after market close on Tuesday, July 30, 2024 at 4:30 PM Eastern Time. A press release with second quarter 2024 financial results will be issued after market close that day.

Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)
Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)

Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 5872954), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.

ADVERTISEMENT

Investor Relations
Penumbra, Inc.
investors@penumbrainc.com
Source: Penumbra, Inc.

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-schedules-second-quarter-2024-earnings-release-and-conference-call-for-july-30-2024-302187271.html

SOURCE Penumbra, Inc.